Visit-to-visit glycated hemoglobin A1c variability in adults with type 2 diabetes: a systematic review and
Furong Qu1, Qingyang Shi2, Yang Wang1
1Department of Endocrinology and Metabolism, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Insights
High glycated hemoglobin (HbA1c) variability increases the risk of death and complications in type 2 diabetes patients. Monitoring HbA1c variability is crucial for managing adverse outcomes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Clinical Research
Background:
- Current type 2 diabetes management relies on the latest glycated hemoglobin (HbA1c) measure.
- HbA1c variability is linked to increased mortality and complications, but its clinical role remains unclear.
- This review examines visit-to-visit HbA1c variability and its association with adverse outcomes in type 2 diabetes.
Approach:
- Systematic review and random-effects meta-analysis.
- Searched PubMed, EMBASE, and CENTRAL for studies on HbA1c variability and adverse outcomes in type 2 diabetes.
- Stratified analysis by HbA1c variability metrics: standard deviation (SD), coefficient of variation (CV), and HbA1c variability score (HVS).
Key Points:
- Elevated HbA1c variability (using SD, CV, or HVS) is associated with higher risks of all-cause mortality.
- High HbA1c variability correlates with increased cardiovascular events, chronic kidney disease progression, amputation, and peripheral neuropathy.
- Hazard ratios indicate significant risk increases for mortality and complications with higher HbA1c variability.
Conclusions:
- High HbA1c variability is a significant risk factor for micro- and macro-vascular complications in type 2 diabetes.
- Increased mortality risk is associated with high HbA1c variability in type 2 diabetes patients.
- Individuals with type 2 diabetes and high HbA1c variability require intensified monitoring and care to mitigate adverse outcomes.
Background:
Current practice uses the latest measure of glycated hemoglobin (HbAlc) to facilitate clinical decision-making. Studies have demonstrated that HbAlc variability links the risk of death and complications of diabetes. However, the role of HbAlc variability is unclear in clinical practice. This systematic review summarized the evidence of visit-to-visit HbAlc variability regarding different metrics in micro- and macro-vascular complications and death in people with type 2 diabetes.
Methods:
We searched PubMed, EMBASE (via OVID), and Cochrane Central Register (CENTRAL, via OVID) for studies investigating the association between HbAlc variability and adverse outcomes in patients with type 2 diabetes and performed random-effects meta-analysis stratified by HbAlc variability metrics in terms of standard deviation (SD), coefficient of variation (CV), and HbAlc variability score (HVS).
Results:
In people with type 2 diabetes, the highest quantile of all three HbAlc variability metrics (HbAlc-standard deviation [HbAlc-SD], HbAlc-coefficient of variance [HbAlc-CV], and HVS) is associated with increased risks of all-cause mortality, cardiovascular events, progression to chronic kidney disease, amputation, and peripheral neuropathy. For example, the hazard ratio of HbAlc-SD on all-cause mortality was l.89 with 95% confidence interval (95% CI) l.46-2.45 (HbAlc-CV l.47, 95% CI l.26-l.72; HVS l.67, 95% CI l.34-2.09).
Conclusions:
High HbAlc variability leads to micro- and macro-vascular complications of type 2 diabetes and related death. People with type 2 diabetes and high HbAlc variability need additional attention and care for the potential adverse outcomes.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...


